RA Capital Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

RA Capital Management’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-483,990	Closed	-$14.8M	–	33
2019 Q2	$14.8M	Buy	483,990 +120,939	+33%	+$2.55M	0.8%	22
2019 Q1	$6.03M	Buy	+363,051	New	+$6.89M	0.26%	29
2018 Q3	–	Sell	-40,000	Closed	-$1.74M	–	29
2018 Q2	$1.74M	Hold	40,000	–	–	0.11%	27
2018 Q1	$1.48M	Sell	40,000 -119,780	-75%	-$3.2M	0.11%	29
2017 Q4	$3.17M	Sell	159,780 -2,524,464	-94%	-$54.3M	0.27%	24
2017 Q3	$49.8M	Hold	2,684,244	–	–	4.5%	7
2017 Q2	$46.8M	Buy	+2,684,244	New	+$47M	5.37%	6

Other funds holding GTHX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

RA Capital Management's GTHX Position: Q3 2019 in Review

RA Capital Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2019, closing a stake of 483,990 shares — an estimated $14.8M sold.

RA Capital Management first reported a position in GTHX in Q2 2017 and held it in 7 quarters. The position peaked at $49.8M in Q3 2017. 99 funds tracked by Wall St. Rank hold GTHX as of Q3 2019.

RA Capital Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
RA Capital Management sold 483,990 G1 Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $14.8M.
RA Capital Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2017 and held it in 7 quarters.
RA Capital Management's G1 Therapeutics, Inc. Common Stock position peaked at $49.8M in Q3 2017.
99 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2019.

Based on RA Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.